 |  | 

Recent advances in the use of vitamin A (retinoids) in the prevention and
treatment of cancer(1).
Niles RM,
Department of Biochemistry and Molecular Biology, Marshall University School
of Medicine, Huntington, West Virginia, USA.
Vitamin A, its physiologic metabolites, and synthetic derivatives (retinoids)
have been shown to have protective effects against the development of certain
types of cancer. In addition, pharmacologic amounts of retinoids have been
used with some success in the treatment of a few human tumors. The
chemoprevention effect of retinoids is most likely exerted at the
tumor-promotion phase of carcinogenesis.
Retinoids block tumor promotion by
inhibiting proliferation, inducing apoptosis, inducing differentiation, or a
combination of these actions. Clinically, isotretinoin (13-cis-retinoic acid)
significantly decreases the incidence of second primary tumors in patients
with head-and-neck cancer and reduces appearance of non-melanoma skin cancer
in patients with xeroderma pigmentosum. Retinoic acid has proved to be an
effective treatment for promyelocytic leukemia.
However, retinoid resistance
limits its use as a single agent. Clinical trials are in progress to
determine the efficacy of retinoids in treating other types of cancer such as
neuroblastoma and breast carcinoma. The development of receptor-selective
retinoids and selective inhibitors of retinoid metabolism may lead to further
use of retinoids in both chemoprevention and treatment of cancer.
Nutrition 2000 Nov-Dec;16(11-12):1084-9
|
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|